scholarly journals Adalimumab-Receiving Ulcerative Colitis Patient Suffered Latent Tuberculosis Reactivation Despite Correct Chemoprophylaxis and was Successfully Treated while on Anti-Tumour Necrosis Factor Therapy

2016 ◽  
Vol 10 (12) ◽  
pp. 1453-1454 ◽  
Author(s):  
Belén Agudo ◽  
Gema Díaz ◽  
Yago González-Lama
Keyword(s):  
Ulcerative Colitis ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Ulcerative Colitis Patient ◽  
Latent Tuberculosis ◽  
Colitis Patient ◽  
Factor Therapy ◽  
Tuberculosis Reactivation ◽  
Necrosis Factor

Anti-Tumour Necrosis Factor Therapy for Ulcerative Colitis

Drugs ◽  
2006 ◽  
Vol 66 (16) ◽  
pp. 2059-2065 ◽  
Author(s):  
Chandrashekhar Thukral ◽  
Adam Cheifetz ◽  
Mark A Peppercorn
Keyword(s):  
Ulcerative Colitis ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Factor Therapy ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document